Literature DB >> 28436273

Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.

Michal Reichert1.   

Abstract

Presented are the results of a study of the expression pattern of different proteins in the course of bovine leukemia virus-induced leukemia in experimental sheep and I discuss how the obtained data may be useful in gaining a better understanding of the pathogenesis of the disease, diagnosis, and for the selection of possible therapeutic targets. In cattle, the disease is characterized by life-long persistent lymphocytosis leading to leukemia/lymphoma in about 5% of infected animals. In sheep, as opposed to cattle, the course of the disease is always fatal and clinical symptoms usually occur within a three-year period after infection. For this reason, sheep are an excellent experimental model of retrovirus-induced leukemia. This model can be useful for human pathology, as bovine leukemia virus is closely related to human T-lymphotropic virus type 1. The data presented here provide novel insights into the molecular mechanisms of the bovine leukemia virus-induced tumorigenic process and indicate the potential marker proteins both for monitoring progression of the disease and as possible targets of pharmacological intervention. A study of the proteome of B lymphocytes from four leukemic sheep revealed 11 proteins with altered expression. Among them, cytoskeleton and intermediate filament proteins were the most abundant, although proteins belonging to the other functional groups, i.e. enzymes, regulatory proteins, and transcription factors, were also present. It was found that trypsin inhibitor, platelet factor 4, thrombospondin 1, vasodilator-stimulated phosphoprotein, fibrinogen alpha chain, zyxin, filamin-A, and vitamin D-binding protein were downregulated, whereas cleavage and polyadenylation specificity factor subunit 5, non-POU domain-containing octamer-binding protein and small glutamine-rich tetratricopeptide repeat-containing protein alpha were upregulated. Discussed are the possible mechanisms of their altered expression and its significance in the bovine leukemia virus-induced leukemogenic process. Impact statement The submitted manuscript provides new data on the molecular mechanisms of BLV-induced tumorigenic process indicating the potential marker proteins both for monitoring the progression of the disease and as possible targets of pharmacological intervention. This is to my knowledge the first study of the proteome of the transformed lymphocytes in the course of bovine leukemia virus-induced leukemia in susceptible animals. BLV can be considered as useful model for related human pathogen - HTLV-1, another member of the deltaretrovirus genus evolutionary closely related to BLV. Information gathered in this study can be useful to speculate on possible shared mechanisms of deltaretrovirus-induced carcinogenesis.

Entities:  

Keywords:  Protein expression; bovine leukemia virus; sheep B lymphocytes

Mesh:

Substances:

Year:  2017        PMID: 28436273      PMCID: PMC5529001          DOI: 10.1177/1535370217705864

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  75 in total

1.  Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells.

Authors:  Le Xuan Truong Nguyen; Steven M Chan; Tri Duc Ngo; Aparna Raval; Kyeong Kyu Kim; Ravindra Majeti; Beverly S Mitchell
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

2.  Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate.

Authors:  Matthew G Rubashkin; Luke Cassereau; Russell Bainer; Christopher C DuFort; Yoshihiro Yui; Guanqing Ou; Matthew J Paszek; Michael W Davidson; Yunn-Yi Chen; Valerie M Weaver
Journal:  Cancer Res       Date:  2014-09-01       Impact factor: 12.701

3.  Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells.

Authors:  Vanessa A Bernusso; João A Machado-Neto; Fernando V Pericole; Karla P Vieira; Adriana S S Duarte; Fabiola Traina; Marc D Hansen; Sara T Olalla Saad; Karin S A Barcellos
Journal:  Biochim Biophys Acta       Date:  2014-11-15

Review 4.  Specific targeted therapy of chronic myelogenous leukemia with imatinib.

Authors:  Michael W N Deininger; Brian J Druker
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

5.  Platelet changes in acute leukemia.

Authors:  Xu Qian; Liu Wen-jun
Journal:  Cell Biochem Biophys       Date:  2013       Impact factor: 2.194

6.  Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and alpha1-antitrypsin in patients with gastrointestinal malignancies.

Authors:  Sylvia Solakidi; Athanassios Dessypris; George P Stathopoulos; George Androulakis; Constantine E Sekeris
Journal:  Clin Biochem       Date:  2004-01       Impact factor: 3.281

7.  Characterization of the cellular binding site for the urinary trypsin inhibitor.

Authors:  H Kobayashi; J Gotoh; M Fujie; T Terao
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

8.  Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.

Authors:  Guo-Gui Sun; Cui-Da Wei; Shao-Wu Jing; Wan-Ning Hu
Journal:  Asian Pac J Cancer Prev       Date:  2014

Review 9.  von Willebrand factor and cancer: a renewed interest.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti; Giuseppe Lippi
Journal:  Thromb Res       Date:  2013-02-08       Impact factor: 3.944

10.  Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia.

Authors:  Abdul Hai; Nadeem A Kizilbash; Syeda Huma H Zaidi; Jamal Alruwaili; Khuram Shahzad
Journal:  Bioinformation       Date:  2014-03-19
View more
  2 in total

1.  Co-Circulation of Bovine Leukemia Virus Haplotypes among Humans, Animals, and Food Products: New Insights of Its Zoonotic Potential.

Authors:  Adriana P Corredor-Figueroa; Nury N Olaya-Galán; Sebastian Velandia-Álvarez; Marina Muñoz; Sandra P Salas-Cárdenas; Milcíades Ibáñez-Pinilla; Manuel A Patarroyo; Maria F Gutiérrez
Journal:  Int J Environ Res Public Health       Date:  2021-05-04       Impact factor: 3.390

Review 2.  Polyglutamine Repeats in Viruses.

Authors:  Catherine H Schein
Journal:  Mol Neurobiol       Date:  2018-09-04       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.